Welcome to the Future of mRNA Process Development & Manufacturing

The 2nd mRNA Process Development & Manufacturing Summitreturned to Boston as the most comprehensive and technical industry dedicated forum, to address key industry bottlenecks from securing quality starting materials, quality by design and automated large-scale manufacturing, to ultimately reduce costs of mRNA production whilst harmonizing with regulatory expectations.   


60+ world-class industry experts including leading mRNA players from Moderna, BioNTech, CureVac, Pfizer and more took center stage across 3 jam-packed days, with3 deep-dive content tracksonresearchscale,IND-enabling&clinical scale, andcommercial scale covering key areas from plasmid DNA manufacturing, in vitro transcription, purification and mRNA drug product development to help accelerate your mRNA drugs into the clinic and through to market.

Attendees were able to join 200+ VPs, DirectorsandHeads of Process Development, Drug Substance, CMC,andMSATat the world’s onlyend-to-endmeeting enabling scalable, cost-effective and commercially viable global mRNA production. 

The 2023 Expert Speaker Faculty Included:

Andreas Kuhn

Senior Vice President - Ribonucleic Acid Biochemistry & Chemistry, Manufacturing, Controls Management

BioNTech SE

Aravindan Rajendran

Senior Principal Scientist Group Leader


Christopher Cheng

VP Process Development & RNA Technology

Verve Therapeutics

Harshal Zope

Director - Manufacturing Science & Technology

Orna Therapeutics

Joseph Schariter

Director – Process Development


Monica Dommel

Associate Director - Regulatory Affairs CMC

CureVac SE

Sung-Hye Grieco

Vice President, Head of Messenger Ribonucleic Acid PD, Manufacturing, Science & Technology , & Program Management Offices

Nutcracker Therapeutics

Yimin Hua

Head of Biochemistry – Analytical Development, mRNA Centre of Excellence


Banners (650 × 130 px) (5)

2023 Lead Partner

Amgen Logo

2023 Expertise Partners

Amgen Logo (1)
Amgen Logo (2)
Amgen Logo (3)